New oral drug for type 2 diabetes shows promise
Thu, 15 Feb 2007 11:01 PM EST
... NEW YORK (Reuters Health) - The first of a new class of oral antidiabetic drugs is able to lower blood sugar (glucose) in type 2 diabetes as well as Avandia (rosiglitazone) does, but without causing weight gain, according to a report in the journal Diabetes Care. ...
Related Topics
- Diabetes - Type 1
- Diabetes - Type 2
- Juvenile Diabetes
- Diabetes and Pregnancy
- Diabetes Insipidus
- Gestational Diabetes
- Oral Health
- Diabetes
- Rosiglitazone
- Drug Safety
- Prescription Drugs
- Type 2 diabetes
- Diabetes Type 1
- Type 1 diabetes
- Drug Side Effects
- Oral Cancer
- Drug Abuse
- Drug Information
- Prescription Drug Abuse
- Prescription Drugs Abuse

Not Signed In -


